Johnson & Johnson (NYSE:JNJ) and Crucell N. V. (NYSE Euronext, Nasdaq:CRXL; Swiss Exchange: CRX) today announced an agreement whereby Johnson & Johnson, by means of an affiliate, would acquire all outstanding equity of Crucell that it does not currently own for around euro 1. 75 billion in a advised cash tender offer (the Offer). Crucell [...]
Related posts:
- SouthernLINC Wireless, A Southern Company(NYSE:SO), Hurricane Help Through Technology
- Stevens-Johnson Syndrome And Kidney Failure Claims Maunte Bol
- Guatemala Syphilis Experiment Exposed – Video
http://tinyurl.com/32sp9b3
No comments:
Post a Comment